Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
Authors:
- Karl R. SchmitzKSKarl R. Schmitz
- Philip D. JeffreyPJPhilip D. Jeffrey
- Jed J.W. WiltziusJWJed J.W. Wiltzius
- Paul KussiePKPaul Kussie
- Kathryn M. FergusonKFKathryn M. Ferguson
Top Cited Papers
- 1 April 2005
- journal article
- Published by Elsevier in Cancer Cell
- Vol. 7 (4) , 301-311
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004
- Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complexCancer Cell, 2004
- Structure of the extracellular region of HER2 alone and in complex with the Herceptin FabNature, 2003
- EGF Activates Its Receptor by Removing Interactions that Autoinhibit Ectodomain DimerizationMolecular Cell, 2003
- Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular DomainsCell, 2002
- Crystal Structure of a Truncated Epidermal Growth Factor Receptor Extracellular Domain Bound to Transforming Growth Factor αCell, 2002
- Use of TLS parameters to model anisotropic displacements in macromolecular refinementActa Crystallographica Section D Structural Biology, 2001
- Extracellular domains drive homo‐ but not hetero‐dimerization of erbB receptorsThe EMBO Journal, 2000
- Shape Complementarity at Protein/Protein InterfacesJournal of Molecular Biology, 1993